[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AT367430B - Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten - Google Patents

Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten

Info

Publication number
AT367430B
AT367430B AT0564879A AT564879A AT367430B AT 367430 B AT367430 B AT 367430B AT 0564879 A AT0564879 A AT 0564879A AT 564879 A AT564879 A AT 564879A AT 367430 B AT367430 B AT 367430B
Authority
AT
Austria
Prior art keywords
hydroxylamino
acid derivatives
producing new
hydrocarbylphosphonic
hydrocarbylphosphonic acid
Prior art date
Application number
AT0564879A
Other languages
English (en)
Other versions
ATA564879A (de
Inventor
Takashi Kamiya
Keiji Hemmi
Masashi Hashimoto
Hidekazu Takeno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ATA564879A publication Critical patent/ATA564879A/de
Application granted granted Critical
Publication of AT367430B publication Critical patent/AT367430B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0564879A 1976-07-27 1979-08-22 Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten AT367430B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof

Publications (2)

Publication Number Publication Date
ATA564879A ATA564879A (de) 1981-11-15
AT367430B true AT367430B (de) 1982-07-12

Family

ID=27258468

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0550977A AT367064B (de) 1976-07-27 1977-07-27 Verfahren zur herstellung von neuen phosphonsaeurederivaten
AT0564879A AT367430B (de) 1976-07-27 1979-08-22 Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0550977A AT367064B (de) 1976-07-27 1977-07-27 Verfahren zur herstellung von neuen phosphonsaeurederivaten

Country Status (21)

Country Link
US (1) US4182758A (de)
JP (1) JPS5340720A (de)
AR (1) AR226522A1 (de)
AT (2) AT367064B (de)
CA (1) CA1091241A (de)
CH (5) CH640862A5 (de)
DE (2) DE2760320C2 (de)
DK (1) DK149609C (de)
ES (3) ES461084A1 (de)
FI (1) FI64377C (de)
FR (1) FR2474505A1 (de)
GB (1) GB1580899A (de)
GR (1) GR61140B (de)
HU (1) HU182023B (de)
IE (1) IE45536B1 (de)
NL (1) NL7708325A (de)
NO (1) NO157504C (de)
OA (1) OA05725A (de)
PH (1) PH14401A (de)
PT (1) PT66854B (de)
SE (1) SE441360B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (de) * 1989-08-31 1991-04-18
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
EP1071409B1 (de) 1998-04-14 2003-10-15 BioAgency AG Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
WO2000003699A2 (de) * 1998-07-15 2000-01-27 Jomaa Hassan Arzneimittel mit einem gehalt an phosphonsäurederivaten als wirkstoff und ihre verwendung
TR200100068T2 (tr) 1998-07-15 2001-06-21 Jomaa,Hassan Fosforlu organik bileşikler ve kullanımları
DE19854403A1 (de) 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
EP1255762A1 (de) * 2000-02-18 2002-11-13 Jomaa Pharmaka GmbH Phosphororganische verbindungen und ihre verwendung
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
US20080300222A1 (en) * 2005-10-06 2008-12-04 Innate Pharma Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
EP1985615A4 (de) * 2006-01-31 2011-12-14 Api Corp Verfahren zur herstellung von benzazepinon
AU2009276343A1 (en) 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (de) 2010-07-06 2012-01-11 BioAgency AG Neue Arzneimittelkombinationen zur Behandlung von Malaria
EP2725029A1 (de) * 2012-10-29 2014-04-30 Laboratoire Biodim Neue antibakterielle Verbindungen und biologische Anwendungen dafür
US12122799B2 (en) 2018-06-18 2024-10-22 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Antibiotics for veterinary staphylococcal infections
US20220401462A1 (en) 2019-10-19 2022-12-22 Dmg Deutsche Malaria Gmbh Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives with clindamycin and artesunate
EP3960176A1 (de) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquin und verwandte arzneimittelkombinationen zur verwendung bei der behandlung von covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (de) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
PT66854B (en) 1978-12-28
ATA564879A (de) 1981-11-15
JPS613799B2 (de) 1986-02-04
ES461084A1 (es) 1978-12-01
OA05725A (fr) 1981-05-31
CA1091241A (en) 1980-12-09
GB1580899A (en) 1980-12-10
FI64377B (fi) 1983-07-29
FI772280A (de) 1978-01-28
DE2733658C2 (de) 1987-06-25
GR61140B (en) 1978-09-23
PT66854A (en) 1977-08-01
DE2733658A1 (de) 1978-02-09
NO157504C (no) 1988-03-30
FI64377C (fi) 1983-11-10
JPS5340720A (en) 1978-04-13
FR2474505B1 (de) 1984-01-27
ATA550977A (de) 1981-10-15
CH640862A5 (de) 1984-01-31
IE45536B1 (en) 1982-09-22
IE45536L (en) 1978-01-27
CH646978A5 (de) 1984-12-28
NO157504B (no) 1987-12-21
CH646980A5 (de) 1984-12-28
DK149609C (da) 1987-02-09
PH14401A (en) 1981-06-25
NL7708325A (nl) 1978-01-31
DK337877A (da) 1978-01-28
AR226522A1 (es) 1982-07-30
AT367064B (de) 1982-05-25
DK149609B (da) 1986-08-11
NO772652L (no) 1978-01-30
CH647807A5 (de) 1985-02-15
DE2760320C2 (de) 1988-11-03
HU182023B (en) 1983-12-28
US4182758A (en) 1980-01-08
SE7708592L (sv) 1978-01-28
ES471822A1 (es) 1979-10-16
CH646979A5 (de) 1984-12-28
FR2474505A1 (fr) 1981-07-31
ES479211A1 (es) 1979-12-16
SE441360B (sv) 1985-09-30

Similar Documents

Publication Publication Date Title
AT358557B (de) Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-phenylthioalkancarbonsaeure- derivaten
AT351164B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT368168B (de) Verfahren zur herstellung von neuen thioetiansaeurederivaten
AT367430B (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
AT369005B (de) Verfahren zur herstellung von neuen cephalosporan-saeurederivaten
AT354626B (de) Verfahren zur herstellung von neuen 7-acyl- amino-8-oxo-3-oxa-1-azabicyclo/4.2.0/octan-2- carbonsaeure-derivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT356814B (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT365564B (de) Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten
AT363181B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT365170B (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT370106B (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT363462B (de) Verfahren zur herstellung von neuen arylalkansaeurederivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
ATA564679A (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
ATA5381A (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT361466B (de) Verfahren zur herstellung von neuen tiophen- derivaten
AT347962B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA345780A (de) Verfahren zur herstellung von neuen 7alphamethoxy-cephalosporansaeurederivaten
ATA564779A (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
ATA685679A (de) Verfahren zur herstellung von neuen 7alpha- -methoxycephalosporansaeurederivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee